GreyBird Ventures
North America, Massachusetts, United States, Concord
Description
GreyBird Ventures medical technology firm and invests in companies developing products for precision medicine.
Investor Profile
GreyBird Ventures has backed more than 7 startups, with 1 new investments in the last 12 months alone. The firm has led 6 rounds, about 86% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series Unknown, Seed rounds (top funding stages).
- Majority of deals are located in United States, Germany, Israel.
- Strong thematic focus on Health Care, Health Diagnostics, Software.
- Led 1 rounds in the past year.
Stage Focus
- Series A (43%)
- Series Unknown (29%)
- Seed (14%)
- Series C (14%)
Country Focus
- United States (29%)
- Germany (29%)
- Israel (29%)
- Austria (14%)
Industry Focus
- Health Care
- Health Diagnostics
- Software
- Biotechnology
- Medical
- Personal Health
- Psychology
- Compliance
- Genetics
- Information Technology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
